Filter your search
Next Generation SequencingX
Sequencing has progressed from a discovery tool in genomics and systems biology to a translational research tool and, within the last five or so years, an instrument of the clinical laboratory. Also referred to as post-Sanger sequencing, next-generation sequencing (NGS) uses massively parallel reactions to perform billions of short reads from sample nucleic acid populations. Expected to exceed $5 billion in market size within this decade, next-generation sequencers will be joined by even faster, smaller and less expensive third-generation sequencers able to be placed more widely in health care and industry.
- $1,500.00 – $3,000.00Next Generation Sequencing Trends (Clinical Applications, Systems Used, Accreditation Status, Regulated Patient Sample Handling and Other Trends) Next-generation sequencing is discussed frequently as a key to clinical diagnostics in the future. This report looks at the status of NGS today, and seeks to provide insights on the “on-the-ground” status of clinical sequencing. In the course […]July 1, 2013